MENU
+Compare
MDXG
Stock ticker: NASDAQ
AS OF
Aug 11, 10:45 AM (EDT)
Price
$7.15
Change
+$0.13 (+1.85%)
Capitalization
1.04B

MDXG MiMedx Group Forecast, Technical & Fundamental Analysis

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone... Show more

Industry: #Biotechnology
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MDXG with price predictions
Aug 08, 2025

MDXG's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MDXG turned positive on July 31, 2025. Looking at past instances where MDXG's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 31, 2025. You may want to consider a long position or call options on MDXG as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MDXG moved above its 50-day moving average on July 21, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MDXG crossed bullishly above the 50-day moving average on July 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDXG advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 189 cases where MDXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MDXG moved out of overbought territory on July 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where MDXG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDXG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MDXG broke above its upper Bollinger Band on July 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.794) is normal, around the industry mean (18.662). P/E Ratio (33.429) is within average values for comparable stocks, (54.033). MDXG's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (2.879) is also within normal values, averaging (286.048).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

View a ticker or compare two or three
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MDXG is expected to report earnings to fall 42.00% to 5 cents per share on October 29

MiMedx Group MDXG Stock Earnings Reports
Q3'25
Est.
$0.06
Q2'25
Beat
by $0.05
Q1'25
Est.
$0.06
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.03
The last earnings report on July 30 showed earnings per share of 10 cents, beating the estimate of 5 cents. With 11.63K shares outstanding, the current market capitalization sits at 1.04B.
A.I. Advisor
published General Information

General Information

a manufacturer of patent protected regenerative biomaterial products and bioimplants

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GVALX14.680.10
+0.69%
Gotham Large Value Institutional
PIDIX13.330.07
+0.53%
Principal International EQ Index Instl
LCBEX32.200.15
+0.47%
ClearBridge Dividend Strategy IS
JDPNX15.740.03
+0.19%
Janus Henderson Mid Cap Value N
VREQX10.20-0.10
-0.97%
NYLI CBRE Real Estate Class R6

MDXG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with INM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-1.27%
INM - MDXG
38%
Loosely correlated
N/A
PCVX - MDXG
36%
Loosely correlated
-0.37%
MGNX - MDXG
33%
Loosely correlated
-4.35%
OMER - MDXG
32%
Poorly correlated
+7.41%
CTMX - MDXG
32%
Poorly correlated
+11.90%
More